Navigation Links
Boehringer Ingelheim Announces Equine Research Awards
Date:12/3/2012

ell as seasonality of Corynebacterium pseudotuberculosis infection and studies of insect vectors.

The topic for the 2013 awards will be announced next spring. Veterinarians, diagnosticians, and public and private researchers in the United States and Canada are eligible to submit proposals. Awards will be selected based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the yearlong studies.

"I am encouraged by the quality of the proposals submitted this year," Dr. Grubbs says. "BIVI is proud to take a leading role in helping provide equine health solutions, but we would not be nearly as successful without the ongoing research conducted by dedicated research and veterinary medical professionals around the country."

For more information and complete submission instructions, please visit www.equinediseaseresearch.com.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expen
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
2. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
3. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
4. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
5. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
6. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
7. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
8. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
11. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... SAN ANTONIO , Jan. 15, 2014 Most ... take, according to a recent online survey* sponsored by ... among the National Osteoporosis Foundation online support community, ... to take medication that comes in a form other ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... Fla., April 20, 2011 Legal-Bay LLC, through its ... making a substantial commitment to plaintiffs in need of ... Cases.  Legal-Bay is already an industry leader; however they ... funding areas.  Recently the company announced that they have ...
... 2011 The Society of ... taking a leading role in measuring and assessing radiation ... and reduction of skin dosage; and promoting the safety ... this month in the Journal of Vascular and Interventional ...
Cached Medicine Technology:Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 3Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 4Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 5
(Date:7/11/2014)... adults who screened positive for a history of hazardous ... than 50 percent after receiving mobile phone text messages ... a study published online yesterday in Annals of ... for Young Adult Emergency Department Patients: A Randomized Clinical ... than 50,000 adults ages 18 to 24 visit ERs ...
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer and retailer, has ... To bring more benefits to worldwide clients in this great ... for these brand new items. Clients can enjoy thwe special ... says gladly, “We are happy to announce such a promotion. ... new and old customers and strengthen our relationship with them. ...
(Date:7/11/2014)... Hills, CA (PRWEB) July 11, 2014 Bedros ... marketing expert; a title he’s earned by founding the fast-selling ... professionals on marketing their businesses. He works with successful boot ... blog post on the traits of the most successful ... earners share three important qualities. , “I’ve worked with and ...
(Date:7/11/2014)... H.E.A.R Me Out Listens to Needs of Hearing ... provide comprehensive information and services available to Colorado’s hearing ... with hearing loss, this organization is the first of ... local and state resources that aims to give new ... Me Out and its website was founded by Colorado ...
(Date:7/11/2014)... is history in much of the world, but remains ... vaccinated children an extra dose of inactivated polio vaccine ... infectious disease, a new study suggests. Although the ... as a year after vaccination. Vaccinated children and adults ... of the disease, according to background information in the ...
Breaking Medicine News(10 mins):Health News:Text message medicine: Texts from the ER can reduce binge drinking 2Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Researchers Assess New Way to Boost Polio Immunity 2
... study has found that among women who have never ... increased risk of developing ovarian cancer compared with women ... issue of CANCER , a peer-reviewed journal of ... may contribute to the development of ovarian cancer through ...
... is urging women to continue waging a battle against the Food ... hormones. , ... Potomac, MD (PRWEB) January 2, 2009 ... health practitioner, is urging women to continue waging a battle against ...
... The National Parkinson Foundation (NPF) awarded ... new evidence-based interventions aimed at preventing falls in ... grants to five different research projects at NPF ... and the United States. NPF supports a ...
... asks you to help save lives by donating blood ... being held on Tuesday, January 6th from 2 pm ... Gloucester City, New Jersey. To make an immediate ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) Goldglantz suffered 3rd ...
... while performing winter task , , FRIDAY, Jan. 2 (HealthDay ... can be physically challenging and dangerous work, so you ... the American Academy of Orthopaedic Surgeons (AAOS). , ... U.S. hospital emergency rooms, doctors, offices, clinics and other ...
... key to understanding, and perhaps killing, dormant ovarian cancer ... years later, researchers at The University of Texas M. ... Journal of Clinical Investigation . , The team found ... a switch for autophagy, or self-cannibalization, in ovarian cancer ...
Cached Medicine News:Health News:Study links obesity to elevated risk of ovarian cancer 2Health News:Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones 2Health News:Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones 3Health News:The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative 2Health News:The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative 3Health News:Blood Drive Held in Honor of Gloucester City Resident - Evan Goldglantz 2Health News:Shovel Snow Safely 2Health News:Dormant cancer cells rely on cellular self-cannibalization to survive 2
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Inoculum Broth with Calcium Chloride and Phytone....
...
Medicine Products: